About pearlcom pearlcom
This author has not yet filled in any details.
New patent covering Enlivex’s Allocetra™ immunotherapy treatment was allowed in Japan pearlcom pearlcom 2019-05-21T12:38:15+03:00
Enlivex appoints former Global Senior Clinical Manager of AJOVY, Teva Pharmaceuticals’ recently-approved migraine drug, as Director of Clinical Operations pearlcom pearlcom 2019-05-05T07:43:00+03:00
Enlivex announces opening of its new Allocetra™ GMP manufacturing facility pearlcom pearlcom 2019-05-05T07:43:23+03:00
New patent covering Enlivex’s Allocetra™ immunotherapy treatment was allowed in Australia pearlcom pearlcom 2019-05-05T07:43:57+03:00
Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. pearlcom pearlcom 2019-05-05T07:38:18+03:00
New patent covering Enlivex’s Allocetra™ immunotherapy treatment was granted by the U.S. patent office pearlcom pearlcom 2019-05-05T07:44:33+03:00
Enlivex announces closing of $5.2 million pre-IPO mezzanine round pearlcom pearlcom 2019-05-05T07:44:58+03:00
Dr. Mohamad Mothy, renowned hematology and transplant expert joins Enlivex’s Clinical Advisory Board pearlcom pearlcom 2019-05-05T07:45:22+03:00
Enlivex appoints former Merck Serono Head of Global Research & Board Member Bernhard Kirschbaum to its Board of Directors pearlcom pearlcom 2019-05-05T07:45:50+03:00
Dr. Mitchell M. Levy renowned Sepsis expert joins Enlivex’s Clinical Advisory Board pearlcom pearlcom 2019-05-05T07:46:21+03:00
Load More Posts
